decentralised trials

R&D

Transforming clinical data management systems for biotechnol...

In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated.

R&D

On a journey to diverse, inclusive, and more efficient rare ...

Although orphan drugs represent a sizeable portion of new drug approvals,1most rare diseases still lack effective treatment.

Digital

Will clinical trials be held in the metaverse? Five ways the...

The pronounced success of increased tech adoption in accelerating and streamlining clinical trials over the past few years has opened the floodgates for a slew of new technology and tactics

Market Access

Upholding regulatory compliance in decentralised trials

Before getting lost in the vast options a decentralised clinical trial (DCT) setup provides, sponsors considering a DCT model need to keep in mind that it is not a one-size-fits-all approac

Digital

Curavit’s crystal ball – how will 2023 drive meaningful chan...

The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways.

Views & Analysis

Bringing the Benefits of eCOA BYOD Strategies to Clinical St...

Over the past few years, many clinical study administrators wanted to use the bring your own device (BYOD) model within their eCOA, but they were typically constrained by regulatory require